🇺🇸 FDA
Pipeline program

A study to assess the safety of ARGX-121 in Healthy Adult Participants

ARGX-121-2401

Phase 1 other active

Quick answer

A study to assess the safety of ARGX-121 in Healthy Adult Participants for Healthy volunteers is a Phase 1 program (other) at Argenx with 1 ClinicalTrials.gov record(s).

Program details

Company
Argenx
Indication
Healthy volunteers
Phase
Phase 1
Modality
other
Status
active

Clinical trials